BACKGROUND: Childhood asthma is most often characterized by recurrent wheezing, airway hyperreactivity, and atopy; however, our understanding of these relationships from early in life remains unclear. Respiratory tract illnesses and atopic sensitization early in life might produce an interaction between innate and acquired immune responses, leading to airway inflammation and heightened airway reactivity. OBJECTIVE: We hypothesized that premorbid airway reactivity and immunologic characteristics of infants without prior episodes of wheezing would be associated with subsequent wheezing during a 1-year follow-up. METHODS: One hundred sixteen infants with chronic dermatitis were enrolled before episodes of wheezing. Airway reactivity, allergen-specific IgE levels, cytokine production by stimulated PBMCs, and percentages of dendritic cells were measured on entry, and airway reactivity was reassessed at the 1-year follow-up. Linear regression models were used to evaluate a predictor's effect on continuous outcomes. RESULTS: Milk sensitization, egg sensitization, or both were associated with heightened airway reactivity before wheezing and after the onset of wheezing; however, these factors were not associated with an increased risk of wheezing. There was an interaction between initial airway reactivity and wheezing as a determinant of airway reactivity at follow-up. In addition, cytokine production by stimulated PBMCs was a risk factor for wheezing, whereas increased percentages of conventional dendritic cells were protective against wheezing. CONCLUSION: Our data in a selected cohort of infants support a model with multiple risk factors for subsequent wheezing that are independent of initial airway reactivity; however, the causative factors that produce wheezing very early in life might contribute to heightened airway reactivity. Copyright (c) 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
BACKGROUND: Childhood asthma is most often characterized by recurrent wheezing, airway hyperreactivity, and atopy; however, our understanding of these relationships from early in life remains unclear. Respiratory tract illnesses and atopic sensitization early in life might produce an interaction between innate and acquired immune responses, leading to airway inflammation and heightened airway reactivity. OBJECTIVE: We hypothesized that premorbid airway reactivity and immunologic characteristics of infants without prior episodes of wheezing would be associated with subsequent wheezing during a 1-year follow-up. METHODS: One hundred sixteen infants with chronic dermatitis were enrolled before episodes of wheezing. Airway reactivity, allergen-specific IgE levels, cytokine production by stimulated PBMCs, and percentages of dendritic cells were measured on entry, and airway reactivity was reassessed at the 1-year follow-up. Linear regression models were used to evaluate a predictor's effect on continuous outcomes. RESULTS: Milk sensitization, egg sensitization, or both were associated with heightened airway reactivity before wheezing and after the onset of wheezing; however, these factors were not associated with an increased risk of wheezing. There was an interaction between initial airway reactivity and wheezing as a determinant of airway reactivity at follow-up. In addition, cytokine production by stimulated PBMCs was a risk factor for wheezing, whereas increased percentages of conventional dendritic cells were protective against wheezing. CONCLUSION: Our data in a selected cohort of infants support a model with multiple risk factors for subsequent wheezing that are independent of initial airway reactivity; however, the causative factors that produce wheezing very early in life might contribute to heightened airway reactivity. Copyright (c) 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Authors: John W Upham; Guicheng Zhang; Angela Rate; Stephanie T Yerkovich; Merci Kusel; Peter D Sly; Patrick G Holt Journal: J Allergy Clin Immunol Date: 2009-09-06 Impact factor: 10.793
Authors: Stefano Guerra; I Carla Lohman; Marilyn Halonen; Fernando D Martinez; Anne L Wright Journal: Am J Respir Crit Care Med Date: 2003-10-02 Impact factor: 21.405
Authors: Daniel Chang; Weiguo Yao; Christina J Tiller; Jeffrey Kisling; James E Slaven; Zhangsheng Yu; Mark H Kaplan; Robert S Tepper Journal: Eur Respir J Date: 2014-09-26 Impact factor: 16.671
Authors: Suzanne Havstad; Christine Cole Johnson; Haejin Kim; Albert M Levin; Edward M Zoratti; Christine L M Joseph; Dennis R Ownby; Ganesa Wegienka Journal: J Allergy Clin Immunol Date: 2014-03-15 Impact factor: 10.793
Authors: Dagan A Loisel; Zheng Tan; Christopher J Tisler; Michael D Evans; Ronald E Gangnon; Daniel J Jackson; James E Gern; Robert F Lemanske; Carole Ober Journal: J Allergy Clin Immunol Date: 2011-07-27 Impact factor: 10.793
Authors: Rukhsana Jabeen; Ritobrata Goswami; Olufolakemi Awe; Aishwarya Kulkarni; Evelyn T Nguyen; Andrea Attenasio; Daniel Walsh; Matthew R Olson; Myung H Kim; Robert S Tepper; Jie Sun; Chang H Kim; Elizabeth J Taparowsky; Baohua Zhou; Mark H Kaplan Journal: J Clin Invest Date: 2013-11 Impact factor: 14.808
Authors: Weiguo Yao; Yanlu Zhang; Rukhsana Jabeen; Evelyn T Nguyen; David S Wilkes; Robert S Tepper; Mark H Kaplan; Baohua Zhou Journal: Immunity Date: 2013-01-31 Impact factor: 31.745
Authors: Edgar E Sarria; Rita Mattiello; Weiguo Yao; Valentina Chakr; Christina J Tiller; Jeffrey Kisling; Rebeka Tabbey; Zhangsheng Yu; Mark H Kaplan; Robert S Tepper Journal: Pediatr Pulmonol Date: 2013-02-08